| P2093 | author name string | Richard Wood-Baker | |
| | Michael A Austin | |
| | Renée Manser | |
| P2860 | cites work | Assessing the quality of reports of randomized clinical trials: is blinding necessary? | Q27860973 |
| | Serevent nationwide surveillance study: comparison of salmeterol with salbutamol in asthmatic patients who require regular bronchodilator treatment | Q35186980 |
| | Effect of inhaled formoterol and budesonide on exacerbations of asthma. Formoterol and Corticosteroids Establishing Therapy (FACET) International Study Group | Q49092631 |
| | Comparison of addition of salmeterol to inhaled steroids with doubling of the dose of inhaled steroids | Q71078827 |
| | Added salmeterol versus higher-dose corticosteroid in asthma patients with symptoms on existing inhaled corticosteroid. Allen & Hanburys Limited UK Study Group | Q72684559 |
| | Formoterol and beclomethasone versus higher dose beclomethasone as maintenance therapy in adult asthma | Q73136764 |
| | Salmeterol/fluticasone propionate (50/500 microg) in combination in a Diskus inhaler (Seretide) is effective and safe in the treatment of steroid-dependent asthma | Q73398082 |
| | One year treatment with salmeterol compared with beclomethasone in children with asthma. The Dutch Paediatric Asthma Study Group | Q73730724 |
| | Effect of long-term salmeterol treatment on exercise-induced asthma | Q74777693 |
| P921 | main subject | asthma | Q35869 |
| P577 | publication date | 2014-08-22 | |
| P1433 | published in | Cochrane Database of Systematic Reviews | Q15750361 |
| P1476 | title | Combined corticosteroid and long-acting beta-agonist in one inhaler for chronic asthma | |